Dr. Kevin Sheth is the Vice Chair for Clinical & Translational Research for Neurology and Neurosurgery at Yale. He is a founding Director of the Yale Center for Brain & Mind Health. His interests are in the advancement of therapies for acute brain injury such as stroke and brain hemorrhage. He is recognized for his leadership in the prevention and acute treatment of stroke. In pioneering the development of new potential strategies to treat stroke, his work has changed the fundamental approach to brain injury in the ICU and spurned the creation of new technologies in drug delivery and neuroimaging, including the deployment of the first portable MRI systems for stroke. His team at Yale has served as a national model for academic critical care neurology units.

He is currently the principal investigator for several NIH neuroscience networks, SIREN and StrokeNet, and multiple additional RO1/UO1 awards from the NIH. Dr. Sheth has served as PI or co-PI for 8 multicenter clinical trials in stroke, as well as chair for clinical endpoint and data safety monitoring committees for several pivotal studies. He leads ASPIRE, one of the first NIH funded prevention studies in brain hemorrhage survivors. He is a winner of the prestigious Robert Siekert, Emergency Neurology and Stroke Mentorship Awards from the American Heart Association (AHA), the Derek Denny Brown Award from the American Neurological Association and he is an elected member of the American Society for Clinical Investigation (ASCI). Overall, the principal theme of his efforts are towards collaboration and an improved understanding of neurological disease.